Literature DB >> 19360377

Pro-inflammatory activity in rats of thiocyanate, a metabolite of the hydrocyanic acid inhaled from tobacco smoke.

Michael Wellesley Whitehouse1, Mark Jones.   

Abstract

OBJECTIVE: To seek a mechanism linking tobacco smoking with the increased incidence and severity of rheumatoid arthritis, deduced from many retrospective surveys, by studying arthritis/fibrosis development in rats.
METHODS: Rats (>300) received low levels of sodium/potassium thiocyanate (10 or 25 mmol/l) in their drinking water to raise their blood thiocyanate levels, mimicking the elevated levels of blood, salivary and urinary thiocyanate found in smokers.
RESULTS: Thiocyanate supplements increased the severity of experimental arthritis induced by tailbase injection of (1) Freund's complete adjuvants (mycobacteria plus various adjuvant-active oils), (2) collagen type-II with Freund's incomplete adjuvant (no mycobacteria), (3) the synthetic lipid amine, avridine in an oil and (4) the natural hydrocarbons squalene (C(30)H(50)) and pristane (C(19)H(40)). This pro-arthritic effect was independent of sex, rat strain or changing diet and housing facilities. Thiocyanate supplements also amplified the acute/persisting inflammatory responses to paw injections of pristane, zymosan and microcrystalline hydroxyapatite. Iodide salts also mimicked some of these effects of thiocyanate.
CONCLUSION: Thiocyanate, a detoxication product of HCN present in tobacco smoke, increased (or even induced) inflammatory responses to several agents causing arthritis or fibrotic inflammation in rats. It, therefore, can act as a co-arthritigen, or 'virulence factor' and could be a therapeutic target to reduce arthritis expression and morbidity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360377     DOI: 10.1007/s00011-009-0038-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  45 in total

1.  The statistical sign test.

Authors:  W J DIXON; A M MOOD
Journal:  J Am Stat Assoc       Date:  1946-12       Impact factor: 5.033

2.  Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Authors:  S P Linn-Rasker; A H M van der Helm-van Mil; F A van Gaalen; M Kloppenburg; R R P de Vries; S le Cessie; F C Breedveld; R E M Toes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

3.  Oxidation of thiocyanate to cyanide and sulfate by the lactoperoxidase-hydrogen peroxide system.

Authors:  J Chung; J L Wood
Journal:  Arch Biochem Biophys       Date:  1970-11       Impact factor: 4.013

4.  Thiocyanate-dependent induction of endothelial cell adhesion molecule expression by phagocyte peroxidases: a novel HOSCN-specific oxidant mechanism to amplify inflammation.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Julia Nguyen; Arne Slungaard
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

5.  Chondrocyte apoptosis induced by nitric oxide.

Authors:  F J Blanco; R L Ochs; H Schwarz; M Lotz
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

6.  Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA.

Authors:  D Hutchinson; L Shepstone; R Moots; J T Lear; M P Lynch
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

7.  Smoking, gender and rheumatoid arthritis-epidemiological clues to etiology. Results from the behavioral risk factor surveillance system.

Authors:  Eswar Krishnan
Journal:  Joint Bone Spine       Date:  2003-12       Impact factor: 4.929

Review 8.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

9.  The influence of cigarette smoking on blood gold distribution during chrysotherapy.

Authors:  D W James; N W Ludvigsen; L G Cleland; S C Milazzo
Journal:  J Rheumatol       Date:  1982 Jul-Aug       Impact factor: 4.666

10.  Thiocyanate, a plausible physiological electron donor of gastric peroxidase.

Authors:  D Das; P K De; R K Banerjee
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

View more
  3 in total

Review 1.  Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver.

Authors:  Michael Whitehouse; Desley Butters; Barrie Vernon-Roberts
Journal:  Inflammopharmacology       Date:  2013-05-19       Impact factor: 4.473

2.  The Association Between Environmental Perchlorate, Nitrate, and Thiocyanate Exposure and Oral Pain in NHANES.

Authors:  Jintao Yu; Jiawen Guo; Hengguo Zhang; Xu Cheng
Journal:  Front Public Health       Date:  2022-03-10

3.  Oral pre-treatment with thiocyanate (SCN-) protects against myocardial ischaemia-reperfusion injury in rats.

Authors:  Luke Hall; Chaouri Guo; Sarah Tandy; Kathryn Broadhouse; Anthony C Dona; Ernst Malle; Emil D Bartels; Christina Christoffersen; Stuart M Grieve; Gemma Figtree; Clare L Hawkins; Michael J Davies
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.